NCT05501834

Brief Summary

This study aims to determine if removing supracondylar pins immediately following cast removal and prior to X-ray and/or using a VR headset during pin removal decreases patient and parent/guardian anxiety compared to pin removal following cast removal and X-ray and/or without the use of a VR headset. The research team hypothesizes that patient anxiety response will be lower when pins are removed immediately following cast removal and will be lower when patient uses a VR headset compared to our current standard of care. Secondarily, this study will determine if there is an association between patient anxiety response and their parent's/guardian's anxiety.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
27mo left

Started Apr 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Apr 2024Oct 2028

First Submitted

Initial submission to the registry

August 2, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 15, 2022

Completed
1.6 years until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2028

Last Updated

June 30, 2026

Status Verified

June 1, 2026

Enrollment Period

4.3 years

First QC Date

August 2, 2022

Last Update Submit

June 25, 2026

Conditions

Keywords

Closed reduction percutaneous pinningSupracondylar Humerus FractureAnxiety

Outcome Measures

Primary Outcomes (2)

  • Face, Legs, Activity, Cry and Consolability (FLACC) scale

    The Face, Legs, Activity, Cry and Consolability scale is validated in both young, non-verbal children and older, verbal children. The FLACC scale measures a patient's response to pain or distress using assessments of (1) facial expression, (2) leg movement, (3) activity, (4) extent to which they cried, and (5) extent to which they are consoled on a scale from 0 to 2 to generate a total score ranging from 0 (no pain/distress) to 10 (maximum pain/distress), with a higher score representing higher rates of anxiety and stress.

    During Treatment (Pin Removal Visit post closed reduction and percutaneous pinning)

  • Heart rate

    Heart rate will be measured using a pulse oximetry heart rate monitor. We plan to use heart rate as a physiological correlate to the FLACC scale. For the purposes of this study, we will define an anxiety response as any patient who scores greater than 0 on the FLACC or achieves a HR in excess of the upper 95% normative limits for their age, sex and race (where applicable).

    During Treatment (Pin Removal Visit post closed reduction and percutaneous pinning)

Secondary Outcomes (2)

  • Spielberger State-Trait Anxiety Inventory (STAI-5)

    During Treatment (Pin Removal Visit post closed reduction and percutaneous pinning)

  • Timing

    During Treatment (Pin Removal Visit post closed reduction and percutaneous pinning)

Study Arms (4)

Control Group

NO INTERVENTION

Arm 1: Control Group Patients in the control group will: 1. Go to cast room for cast removal, 2. Go to radiology for X-ray, 3. Be seen in clinic room for pin removal. These steps are our current standard of care. An orthopedic cast room technician bivalves and removes the top half of the patient's cast. In radiology, anteroposterior (AP) and lateral X-ray views are obtained to confirm radiographic healing. In the clinic room, a surgeon or nurse removes the pins using pin removal pliers

Intervention Group 1

EXPERIMENTAL

Arm 2: No change in clinic order, VR headset intervention Patients in arm two will: 1. Go to cast room for cast removal, 2. Go to radiology for X-ray, 3. Receive a VR headset to wear while in clinic room, 4. Be seen in clinic room for pin removal

Other: Supracondylar Pin Removal After Imaging With VR

Intervention Group 2

EXPERIMENTAL

Arm 3: Change in clinic order, no VR headset intervention Patients in arm three will: 1. Go to cast room for cast removal, 2. Have pins immediately pulled after cast removal, 3. Go to radiology for X-ray, 4. Be seen in clinic room by provider

Other: Supracondylar Pin Removal Before Imaging

Intervention Group 3

EXPERIMENTAL

Arm 4: Change in clinic order and VR headset intervention Patients in arm four will: 1. Receive a VR headset to wear while in cast room, 2. Go to cast room for cast removal, 3. Have pins immediately pulled after cast removal, 4. Go to radiology for X-ray, 5. Be seen in clinic room by provider

Other: Supracondylar Pin Removal Before Imaging With VR

Interventions

Patients in the intervention 1 group will: 1. Go to cast room for cast removal, 2. Have pins pulled in cast room by provider, 3. Go to radiology for X-ray, 4. Have clinic visit with provider

Intervention Group 2

Patients in the treatment group will: 1. Go to cast room for cast removal, 2. Go to radiology for X-ray, 3. Wear the VR headset, 4. Have pins pulled in clinic room by provider.

Intervention Group 1

Patients in the intervention group 2 will: 1. Go to cast room for cast removal, 2. Wear the VR headset, 3. Have pins pulled in cast room by provider, 4. Go to radiology for X-ray

Intervention Group 3

Eligibility Criteria

Age3 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Aged 3 to ≤10 years at time of surgery
  • Supracondylar humerus fractures that are laterally pinned at Boston Children's Hospital
  • Scheduled visit for pin removal at either Boston or Waltham orthopedic clinic by a study-participating physician
  • English speaking

You may not qualify if:

  • Documented history of seizure disorders or other neurological disorders.
  • Patients unwilling to follow up in Boston or Waltham BCH clinic locations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Children's Hospital

Boston, Massachusetts, 02215, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Yi-Meng Yen, MD, PhD

    Boston Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Orthopedic Surgery, Harvard Medical School

Study Record Dates

First Submitted

August 2, 2022

First Posted

August 15, 2022

Study Start

April 1, 2024

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

October 1, 2028

Last Updated

June 30, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations